Pfizer’s chief executive tests positive for ‘COVID-19’ for second time in two months

Pfizer’s chief executive has tested positive for COVID-19 for the second time in two months.

Albert Bourla, the head of the company that created one of the most widely used coronavirus vaccines, said he was “feeling well and symptom free”.

Mr Bourla, 60, contacted COVID back in August and had started a course of the company’s oral COVID-19 antiviral treatment, Paxlovid.

Paxlovid is an antiviral medication used to treat high-risk people, such as older patients.

Mr Bourla has received four doses of the vaccine his company developed alongside its German partner BioNTech – but said he missed out on getting the new bivalent booster due to contracting the disease in recent months.

Read more: Pfizer’s chief executive tests positive for COVID-19 for second time in two months